Masahide Oshita, Yoshiyuki Takei, Sunao Kawano, Taizo Hijioka, Eiji Masuda, Moritaka Goto, Yoshiya Nishimura, Hirotaka Nagai, Sadaharu Iio, Shingo Tsuji, Hideyuki Fusamoto, Takenobu Kamada – 1 October 1994 – The purpose of this study was to clarify the role of endogenous nitric oxide in ethanol‐induced perturbation of microcirculation and hepatic injury in perfused rat liver. Infusion of ethanol into the portal vein at 25 and 100 mmol/L increased portal pressure, which is an indicator of hepatic vasoconstriction, in a concentration‐dependent fashion.

F. Xavier González, Antoni Rimola, Luis Grande, Maria Antolin, Juan C. Garcia‐Valdecasas, Jose Fuster, Antonio M. Lacy, Esteban Cugat, Jose Visa, Joan Rodés – 1 September 1994 – To identify factors predictive of early postoperative graft function, we analyzed 54 variables—including easily available clinical and laboratory data prospectively obtained from organ donors, transplant recipients and surgical procedures in 168 consecutive liver transplantations.

Joseph S. Galati, Howard P. Monsour, Jeremiah P. Donovan, Rowen K. Zetterman, Daniel F. Schafer, Alan N. Langnas, Byers W. Shaw, Michael F. Sorrell – 1 September 1994 – Liver biopsy is an important diagnostic tool in the management of patients following orthotopic liver transplant. We evaluated complications following percutaneous liver biopsy in a group of liver transplant patients who had Roux‐en‐Y choledochojejunostomies fashioned as part of their biliary reconstruction during liver transplantation.

Sumiko Nagoshi, Kenji Fujiwara – 1 September 1994 – Putrescine can stimulate regeneration of the remnant liver after partial hepatectomy in rats when exogenously administered, but its mitogenic action has not been shown in cultured hepatocytes. To find its action site(s) in the regulation of hepatocyte proliferation, we examined its effect on hepatocyte DNA synthesis in relation to mitogenic action of epidermal growth factor in vitro and in vivo.

Shinichi Iwamura, Hideaki Enzan, Toshiji Saibara, Saburo Onishi, Yasutake Yamamoto – 1 September 1994 – Sinusoidal “inclusion‐containing endothelial cells” were studied histopathologically and immunohistochemically in various liver diseases, and their clinical importance was investigated. A total of 498 needle liver biopsies were examined. Endothelial inclusions inside the cells were recognized as eosinophilic granules in hematoxylin‐eosin‐stained sections. Electron microscopy showed that these inclusions corresponded to round cytoplasmic dense bodies with a single limiting membrane.

Keril Blight, Richard R. Lesniewski, Justin T. Labrooy, Eric J. Gowans – 1 September 1994 – Hepatitis C virus antigen expression was examined using peptide antibodies in liver tissue taken at biopsy from four chronic carriers of hepatitis C virus. Hepatitis C virus antigens E2/NS1, NS3, NS4 and NS5 were widespread in unfixed frozen liver sections and were present as distinct granules or foci within the cytoplasm of hepatocytes and in infiltrating lymphocytes in portal tracts.

Peter R. Sinclair, William J. Bement, John F. Healey, Nadia Gorman, Jacqueline F. Sinclair, Herbert L. Bonkovsky, Heng H. Liem, Ursula Muller‐Eberhard – 1 September 1994 – The serum protein hemopexin is considered to have a major role in the mechanism of the uptake of heme by hepatocytes by means of a heme‐hemopexin receptor.

Eric A. Argao, William F. Balistreri, Bruce W. Hollis, Frederick C. Ryckman, James E. Heubi – 1 September 1994 – Almost all infants and children with chronic cholestasis have osteopenia. We evaluated the effect of orthotopic liver transplantation on bone mineral content and serum 25(OH)‐vitamin D–[25(OH)D]–of nine infants and children (five girls; age, 6 to 21 mo at the time of orthotopic liver transplantation) with end‐stage liver disease resulting from chronic cholestasis.

K. Sandy Pang, Igor A. Sherman, Andreas J. Schwab, Wanping Geng, Ford Barker, John A. Dlugosz, Guy Cuerrier, Carl A.

Jordi Bruix, Antoni Castells, Xavier Montanyà, Xavier Calvet, Concepció Brü, Carmen Ayuso, Lluís Jover, Laura García, Ramon Vilana, Loreto Boix, Joan Rodés – 1 September 1994 – Our uncontrolled phase II study was aimed at assessing the efficacy of transarterial embolization in patients with hepatocellular carcinoma and to determine the parameters associated with a favorable response to treatment, improved survival or both. Fifty consecutive patients (25 corresponding to Okuda's stage I and 25 to stage II) with hepatocellular carcinoma (41 being multinodular or massive) were included.